Research suggests that targeting the inflammasome may help prevent adverse perinatal outcomes associated with recurrent chronic intervillositis of unknown etiology. Studies have investigated the role of inflammation and immune responses in pregnancy complications, including preterm birth and stillbirth. The relationship between chronic intervillositis and adverse perinatal outcomes is being explored through various methods, including observational studies and transcriptomic profiling.